Ghanaatgar Kasbi, S.; Savard, M.; Couture, F.; Dubuc, C.; Dumulon-Perreault, V.; Nepveu-Traversy, M.-E.; Ait-Mohand, S.; Sabbagh, R.; Geha, S.; Guérin, B.;
et al. Theranostic Potential of a New 64Cu-Labeled NOTA-R954 Peptide Conjugate for Kinin B1R Expressing Prostate Cancer. Pharmaceutics 2025, 17, 1215.
https://doi.org/10.3390/pharmaceutics17091215
AMA Style
Ghanaatgar Kasbi S, Savard M, Couture F, Dubuc C, Dumulon-Perreault V, Nepveu-Traversy M-E, Ait-Mohand S, Sabbagh R, Geha S, Guérin B,
et al. Theranostic Potential of a New 64Cu-Labeled NOTA-R954 Peptide Conjugate for Kinin B1R Expressing Prostate Cancer. Pharmaceutics. 2025; 17(9):1215.
https://doi.org/10.3390/pharmaceutics17091215
Chicago/Turabian Style
Ghanaatgar Kasbi, Sadaf, Martin Savard, Frédéric Couture, Céléna Dubuc, Véronique Dumulon-Perreault, Marie-Edith Nepveu-Traversy, Samia Ait-Mohand, Robert Sabbagh, Sameh Geha, Brigitte Guérin,
and et al. 2025. "Theranostic Potential of a New 64Cu-Labeled NOTA-R954 Peptide Conjugate for Kinin B1R Expressing Prostate Cancer" Pharmaceutics 17, no. 9: 1215.
https://doi.org/10.3390/pharmaceutics17091215
APA Style
Ghanaatgar Kasbi, S., Savard, M., Couture, F., Dubuc, C., Dumulon-Perreault, V., Nepveu-Traversy, M.-E., Ait-Mohand, S., Sabbagh, R., Geha, S., Guérin, B., Dory, Y., & Gobeil, F.
(2025). Theranostic Potential of a New 64Cu-Labeled NOTA-R954 Peptide Conjugate for Kinin B1R Expressing Prostate Cancer. Pharmaceutics, 17(9), 1215.
https://doi.org/10.3390/pharmaceutics17091215
